Product Description: Amiselimod (MT-1303) is a modulator for sphingosine 1-phosphate receptor (S1P receptor). Amiselimod converses to its active metabolite (S)-amiselimod phosphate by sphingosine kinases (SPHKs), targets S1P1 receptor, ameliorates the autoimmune disease without causing bradycardia[1].
Applications: COVID-19-immunoregulation
Formula: C19H30F3NO3
References: [1]Sugahara K, et al., Amiselimod, a novel sphingosine 1-phosphate receptor-1 modulator, has potent therapeutic efficacy for autoimmune diseases, with low bradycardia risk. Br J Pharmacol. 2017 Jan;174(1):15-27.
CAS Number: 942399-20-4
Molecular Weight: 377.44
Research Area: Inflammation/Immunology
Target: LPL Receptor